Gilead Sciences, Inc. (GILD) 재무상태표
NASDAQ · Healthcare · Drug Manufacturers - General · 직원 17,000명 · CEO Daniel O'Day
- 주가
- $170.68 +3.06%
- 시가총액
- $2120억
- 기업가치
- $2310억
- 최근 실적
- Q3 '26 2026-10-30 제출
- 다음 실적
- 2027-02-09 EPS 추정 $1.39
Gilead Sciences, Inc. (GILD)의 Q3 '26말 현금 및 단기투자는 $64.4억, 리스 포함 차입금은 $262억입니다. 자산총계 $514억, 부채총계 $385억, 주주지분 $130억.
재무상태표
| 재무상태표 | 추세 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $60.9억 | $47.2억 | $27.7억 | $50.4억 | $99.9억 | $79.3억 | $51.4억 | $73.3억 | $75.6억 | $76.3억 | $31.8억 | $64.4억 | |
| 단기투자 | $22.7억 | $13.4억 | $14.3억 | $16.6억 | $15.8억 | $0 | $6900만 | $1900만 | $20.5억 | $1500만 | $0 | $0 | |
| 매출채권 | $46.6억 | $46.7억 | $46.6억 | $45.9억 | $44.2억 | $43.9억 | $47.8억 | $51억 | $49.1억 | $47.4억 | $50.6억 | $50.1억 | |
| 재고자산 | $17.9억 | $18.5억 | $20.3억 | $18.7억 | $17.1억 | $17.6억 | $18.3억 | $17.9억 | $17.7억 | $19.1억 | $19.5억 | $19억 | |
| 기타 유동자산 | $12.9억 | $14.6억 | $14.3억 | $16.3억 | $9.95억 | $28.3억 | $29억 | $36.5억 | $11.4억 | $43.4억 | $37.6억 | $32.1억 | |
| 유동자산 | $161억 | $140억 | $123억 | $148억 | $192억 | $169억 | $147억 | $179억 | $183억 | $186억 | $139억 | $166억 | |
| 유형자산(순액) | $53.2억 | $53.2억 | $53.5억 | $53.9억 | $54.1억 | $54.2억 | $54.6억 | $55억 | $56.1억 | $56.4억 | $58.3억 | $59.5억 | |
| 장기투자 | $21.6억 | $11.4억 | $7.1억 | $7.3억 | $0 | $6.84억 | $19.1억 | $20.1억 | $29.7억 | $9.83억 | $0 | $0 | |
| 영업권 | $83.1억 | $83.1억 | $83.1억 | $83.1억 | $83.1억 | $83.1억 | $83.1억 | $83.1억 | $83.1억 | $83.1억 | $83.1억 | $83.1억 | |
| 무형자산 | $265억 | $234억 | $228억 | $205억 | $199억 | $194억 | $186억 | $180억 | $170억 | $164억 | $140억 | $134억 | |
| 이연법인세자산 | $0 | $0 | $0 | $0 | $23.8억 | $25.7억 | $27.2억 | $20억 | $19.6억 | $17.7억 | $24.9억 | $22.7억 | |
| 기타 비유동자산 | $38억 | $40.4억 | $40.6억 | $47.6억 | $37.7억 | $31.9억 | $40.3억 | $48.7억 | $48.5억 | $45.5억 | $47.5억 | $49억 | |
| 비유동자산 | $460억 | $423억 | $413억 | $397억 | $398억 | $395억 | $410억 | $407억 | $407억 | $376억 | $354억 | $349억 | |
| 자산총계 | $621억 | $563억 | $536억 | $545억 | $590억 | $564억 | $557억 | $585억 | $590억 | $563억 | $494억 | $514억 | |
| 부채 | |||||||||||||
| 매입채무 | $5.5억 | $6.22억 | $5.37억 | $9.03억 | $8.33억 | $7.37억 | $5.82억 | $8.08억 | $7.15억 | $6.45억 | $6.74억 | $9.34억 | |
| 미지급비용 | $38억 | $42.6억 | $39.2억 | $41.1억 | $38.9억 | $41.9억 | $42.2억 | $49.3억 | $43.4억 | $41.2억 | $42.3억 | $46.2억 | |
| 단기차입금 | $18억 | $36.7억 | $18.1억 | $18.1억 | $18.2억 | $28.1억 | $28.1억 | $28.1억 | $28.1억 | $13.1억 | $24.1억 | $24.2억 | |
| 미지급세금 | $12.1억 | $12억 | $12.7억 | $15.4억 | $16.5억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 기타 유동부채 | $38억 | $32.7억 | $32.5억 | $33.6억 | $37.1억 | $46.2억 | $35.9억 | $37.5억 | $38.6억 | $34억 | $37억 | $40.3억 | |
| 유동부채 | $113억 | $130억 | $108억 | $117억 | $120억 | $123억 | $112억 | $123억 | $118억 | $94.8억 | $110억 | $120억 | |
| 장기차입금 | $232억 | $215억 | $215억 | $214억 | $249억 | $221억 | $221억 | $221억 | $221억 | $209억 | $238억 | $238억 | |
| 리스부채(비유동) | $5.46억 | $0 | $0 | $0 | $4.98억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 이연법인세부채 | $15.9억 | $9.33억 | $9.07억 | $7.94억 | $7.24억 | $7.09억 | $6.52억 | $5.97억 | $4.02억 | $3.92억 | $3.33억 | $3.18억 | |
| 기타 비유동부채 | $27.7억 | $33.6억 | $21.6억 | $21.8억 | $16.3억 | $21.6억 | $21.5억 | $20.5억 | $20.6억 | $21.2억 | $24.3억 | $23.2억 | |
| 비유동부채 | $281억 | $258억 | $246억 | $244억 | $277억 | $250억 | $249억 | $248억 | $246억 | $234억 | $266억 | $265억 | |
| 부채총계 | $394억 | $388억 | $354억 | $361억 | $397억 | $374억 | $361억 | $371억 | $364억 | $328억 | $376억 | $385억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | |
| 이익잉여금 | $163억 | $107억 | $112억 | $111억 | $115억 | $109억 | $113억 | $128억 | $137억 | $141억 | $22억 | $31.1억 | |
| 기타포괄손익누계액 | $2800만 | $6900만 | $9300만 | $7300만 | $1.32억 | $9200만 | -$1800만 | $3600만 | $3900만 | $7800만 | $9500만 | $8900만 | |
| 주주지분 | $228억 | $175억 | $183억 | $185억 | $193억 | $192억 | $197억 | $215억 | $227억 | $235억 | $118억 | $130억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $257억 | $252억 | $234억 | $232억 | $273억 | $250억 | $249억 | $249억 | $249억 | $222억 | $262억 | $262억 | |
| 순차입금(차입금 - 현금) | $196억 | $205억 | $206억 | $182억 | $173억 | $170억 | $198억 | $176억 | $174억 | $145억 | $231억 | $198억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $82.3억 | $75.9억 | $179억 | $116억 | $60억 | $53.4억 | $54.1억 | $60.9억 | $99.9억 | $75.6억 | |
| 단기투자 | $36.7억 | $179억 | $121억 | $127억 | $14.1억 | $11.8억 | $9.73억 | $11.8억 | $15.8억 | $20.5억 | |
| 매출채권 | $45.1억 | $38.5억 | $33.3억 | $35.8억 | $48.9억 | $44.9억 | $47.8억 | $46.6억 | $44.2억 | $49.1억 | |
| 재고자산 | $15.9억 | $8.01억 | $8.14억 | $9.22억 | $16.8억 | $16.2억 | $15.1억 | $17.9억 | $17.1억 | $17.7억 | |
| 기타 유동자산 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $23.7억 | $9.95억 | $11.4억 | |
| 유동자산 | $196억 | $318억 | $358억 | $303억 | $160억 | $148억 | $144억 | $161억 | $192억 | $183억 | |
| 유형자산(순액) | $28.7억 | $33억 | $40.1억 | $45억 | $49.7억 | $51.2억 | $54.8억 | $53.2억 | $54.1억 | $56.1억 | |
| 장기투자 | $205억 | $112억 | $14.2억 | $14.9억 | $5.02억 | $13.1억 | $12.5억 | $11.6억 | $0 | $29.7억 | |
| 영업권 | $11.7억 | $41.6억 | $41.2억 | $41.2억 | $81.1억 | $83.3억 | $83.1억 | $83.1억 | $83.1억 | $83.1억 | |
| 무형자산 | $89.7억 | $171억 | $157억 | $138억 | $331억 | $335억 | $289억 | $265억 | $199억 | $170억 | |
| 이연법인세자산 | $4.02억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $23.8억 | $19.6억 | |
| 기타 비유동자산 | $34.9억 | $27.2억 | $25.6억 | $74.4억 | $57.1억 | $49.6억 | $48억 | $47.9억 | $37.7억 | $48.5억 | |
| 비유동자산 | $374억 | $385억 | $278억 | $313억 | $524억 | $532억 | $487억 | $460억 | $398억 | $407억 | |
| 자산총계 | $570억 | $703억 | $637억 | $616억 | $684억 | $680억 | $632억 | $621억 | $590억 | $590억 | |
| 부채 | |||||||||||
| 매입채무 | $12.1억 | $8.14억 | $7.9억 | $7.13억 | $8.44억 | $7.05억 | $9.05억 | $5.5억 | $8.33억 | $7.15억 | |
| 미지급비용 | $74.3억 | $69.1억 | $63.2억 | $55.2억 | $57.5억 | $74.2억 | $34.8억 | $38억 | $38.9억 | $43.4억 | |
| 단기차입금 | $0 | $27.5억 | $27.5억 | $25억 | $27.6억 | $15.2억 | $22.7억 | $18억 | $18.2억 | $28.1억 | |
| 미지급세금 | $17.5억 | $7.13억 | $1.9억 | $2.87억 | $5.98억 | $5.39억 | $9.59억 | $12.1억 | $8.3억 | $0 | |
| 이연수익 | $2.02억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 기타 유동부채 | $1.96억 | $4.55억 | $5.55억 | $7.36억 | $14.5억 | $14.3억 | $36.2억 | $39.2억 | $38.2억 | $38.6억 | |
| 유동부채 | $92.2억 | $116억 | $106억 | $97.6억 | $114억 | $116억 | $112억 | $113억 | $120억 | $118억 | |
| 장기차입금 | $263억 | $308억 | $246억 | $221억 | $286억 | $252억 | $230억 | $232억 | $249억 | $221억 | |
| 이연법인세부채 | $0 | $0 | $0 | $0 | $39.1억 | $43.6억 | $26.7억 | $15.9억 | $7.24억 | $4.02억 | |
| 기타 비유동부채 | $20.5억 | $73.5억 | $69.6억 | $71.2억 | $62.3억 | $57.4억 | $50.9억 | $33.2억 | $21.3억 | $20.6억 | |
| 비유동부채 | $284억 | $381억 | $315억 | $292억 | $388억 | $353억 | $307억 | $281억 | $277억 | $246억 | |
| 부채총계 | $376억 | $498억 | $421억 | $390억 | $502억 | $469억 | $420억 | $394억 | $397억 | $364억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | $100만 | |
| 이익잉여금 | $182억 | $190억 | $190억 | $194억 | $144억 | $163억 | $157억 | $163억 | $115억 | $137억 | |
| 기타포괄손익누계액 | $2.78억 | $1.65억 | $8000만 | $8500만 | -$6000만 | $8300만 | $200만 | $2800만 | $1.32억 | $3900만 | |
| 주주지분 | $189억 | $204억 | $214억 | $225억 | $182억 | $211억 | $212억 | $228억 | $193억 | $227억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $263억 | $335억 | $273억 | $246억 | $314억 | $267억 | $252억 | $250억 | $267억 | $249억 | |
| 순차입금(차입금 - 현금) | $181억 | $260억 | $93.8억 | $130억 | $254억 | $214억 | $198억 | $189억 | $167억 | $174억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
데이터 기준일 2026-11-01